Assessing treatment switch among patients with multiple sclerosis: A machine learning approach
Background: Patients with multiple sclerosis (MS) frequently switch their Disease-Modifying Agents (DMA) for effectiveness and safety concerns. This study aimed to develop and compare the random forest (RF) machine learning (ML) model with the logistic regression (LR) model for predicting DMA switch...
Saved in:
Main Authors: | Jieni Li (Author), Yinan Huang (Author), George J. Hutton (Author), Rajender R. Aparasu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Performance of advanced machine learning algorithms overlogistic regression in predicting hospital readmissions: A meta-analysis
by: Ashna Talwar, et al.
Published: (2023) -
Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis
by: Jagadeswara Rao Earla, et al.
Published: (2021) -
Predicting disease activity in patients with multiple sclerosis: An explainable machine‐learning approach in the Mavenclad trials
by: Sreetama Basu, et al.
Published: (2022) -
Novel approaches in the treatment of multiple sclerosis
by: Stepanović-Petrović Radica, et al.
Published: (2015) -
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
by: Martin Vališ, et al.
Published: (2023)